Literature DB >> 16969985

Serious ocular complications of zoledronate.

T C S Woo1, D J Joseph, R Wilkinson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969985     DOI: 10.1016/j.clon.2006.04.013

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  5 in total

Review 1.  Ocular side effects of bisphosphonates: A case report and literature review.

Authors:  Meredith McKague; Derek Jorgenson; Kelly A Buxton
Journal:  Can Fam Physician       Date:  2010-10       Impact factor: 3.275

2.  Risk of Cataract Surgery and Age-Related Macular Degeneration After Initiation of Denosumab vs Zoledronic Acid for Osteoporosis: A Multi-Database Cohort Study.

Authors:  Hemin Lee; Yinzhu Jin; Miin Roh; Theodore N Tsacogianis; Sangshin Park; Nam-Kyong Choi; Seoyoung C Kim
Journal:  Drugs Aging       Date:  2020-04       Impact factor: 3.923

3.  Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial.

Authors:  D V Patel; M Bolland; Z Nisa; F Al-Abuwsi; M Singh; A Horne; I R Reid; C N J McGhee
Journal:  Osteoporos Int       Date:  2014-09-04       Impact factor: 4.507

4.  Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  F Procianoy; E Procianoy
Journal:  Osteoporos Int       Date:  2009-10-27       Impact factor: 4.507

Review 5.  Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report.

Authors:  Yiming Tian; Rui Wang; Lianyuan Liu; Chunming Ma; Qiang Lu; Fuzai Yin
Journal:  BMC Musculoskelet Disord       Date:  2016-02-11       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.